Antibody-based protocol for the treatment of chronic antibody mediated kidney transplant rejection.

被引：0
|
作者：
Samaniego, M. [1 ]
Pascual, J. [1 ]
Djamali, A. [1 ]
Torrealba, J. [1 ]
Zachariah, M. [1 ]
Voss, B. [1 ]
Sollinger, H. [1 ]
Pirsch, J. [1 ]
机构：
[1] Univ Wisconsin, Dept Surg & Med, Madison, WI 53706 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2007年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
434
引用
收藏
页码：260 / 260
页数：1
相关论文
共 50 条
  • [1] Not all transplant glomerulopathy is due to chronic antibody mediated rejection.
    Dinavahi, Rajani
    Dikman, Steven
    Murphy, Barbara
    Sehgal, Vinita
    Schroppel, Bernd
    de Boccardo, Graciela
    Bromberg, Jonathan S.
    Akalin, Enver
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 259 - 259
  • [2] Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients
    Khairallah, Pascale
    Robbins-Juarez, Shelief
    Patel, Shefali
    Shah, Vaqar
    Toma, Katherine
    Fernandez, Hilda
    Dube, Geoffrey K. K.
    King, Kristen
    Mohan, Sumit
    Husain, Syed Ali
    Morris, Heather
    Crew, Russell John
    [J]. CLINICAL TRANSPLANTATION, 2023, 37 (01)
  • [3] Not all transplant glomerulopathy related to chronic antibody-mediated rejection.
    Akalin, Enver
    Barbachan e Silva, Mariel
    Mustofa, Sadia
    Bao, Yi
    Broin, Pilib O.
    [J]. TRANSPLANTATION, 2024, 108 (09) : 18 - 18
  • [4] Tocilizumab as Treatment for Persistent Chronic Active Antibody Mediated Rejection.
    Fernandez, H.
    Patel, S.
    Chiles, M.
    Ratner, L.
    Crew, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 606 - 606
  • [5] Plasmapheresis in Chronic Active Antibody Mediated Rejection.
    Oguz, E. Gok
    Yildirim, T.
    Merhametsiz, O.
    Haspulat, A.
    Ercan, Z.
    Gursoy, G. Karaveli
    Bulut, C.
    Akoglu, H.
    Akdag, I.
    Canbakan, B.
    Ayli, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 677 - 677
  • [6] Plasmapheresis in Chronic Active Antibody Mediated Rejection.
    Oguz, E. Gok
    Yildirim, T.
    Merhametsiz, O.
    Haspulat, A.
    Ercan, Z.
    Gursoy, G. Karaveli
    Bulut, C.
    Akoglu, H.
    Akdag, I.
    Canbakan, B.
    Ayli, D.
    [J]. TRANSPLANTATION, 2014, 98 : 677 - 677
  • [7] Mechanism and treatment for chronic antibody-mediated rejection in kidney transplant recipients
    Sasaki, Hajime
    Tanabe, Tatsu
    Tsuji, Takahiro
    Hotta, Kiyohiko
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (08) : 624 - 633
  • [8] Mouse Models That Fully Reproduce Human Acute and Chronic Antibody-Mediated Kidney Transplant Rejection.
    Chow, A.
    Pearcey, J.
    Ho, T.
    Raghuveer, A.
    Kuttikat, P.
    Zhu, L.
    Sis, B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 464 - 464
  • [9] Predictors of Response to Belatacept Conversion in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection.
    Kumar, D.
    Winstead, R.
    Iftikhar, H.
    Minniti, R.
    Khorsandi, S.
    Christensen, J.
    Yakubu, I.
    Moinuddin, I.
    Kamal, L.
    Halloran, P.
    Gupta, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 385 - 386
  • [10] Identification of Antibodies Reactive to Vimentin in a Rat Kidney Transplant Model of Chronic Antibody-Mediated Rejection.
    Reese, S.
    Wilson, N.
    Ptak, L.
    Sullivan, J.
    Burlingham, W.
    Djamali, A.
    Panzer, S. E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 604 - 605
12345